MedPath
NMPA Approval

Reduced Glutathione for Injection

国药准字HJ20181207

June 7, 2023

H20181207

Drug Information

注射用还原型谷胱甘肽

泰特

注射剂

600mg(以C₁₀H₁₇N₃O₆S计)

化学药品

June 7, 2023

June 6, 2028

Company Information

Applicant Company

Via Morolense,87 Ferentino

Manufacturing Company

Via Morolense,87 Ferentino

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用还原型谷胱甘肽 - NMPA 批准文号 | MedPath